3-Bromo-4-methyl-2-pyridinamine | CAS:40073-38-9

We serve 3-Bromo-4-methyl-2-pyridinamine CAS:40073-38-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Bromo-4-methyl-2-pyridinamine

Chemical Name:3-Bromo-4-methyl-2-pyridinamine
CAS.NO:40073-38-9
Synonyms:3-Bromo-4-methyl-2-pyridinamine
2-Amino-3-bromo-4-picoline
3-Bromo-4-methylpyridin-2-amine
 
Physical and Chemical Properties:
Density 1.6±0.1 g/cm3
Boiling Point 255.2±35.0 °C at 760 mmHg
Molecular Formula C6H7BrN2
Molecular Weight 187.037
Flash Point 108.2±25.9 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.617
 
Specification:
Appearance:Off-white to light yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 3-Bromo-4-methyl-2-pyridinamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-4-methylpyridin-2-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-3-bromo-4-picoline Use and application,3-Bromo-4-methylpyridin-2-amine technical grade,usp/ep/jp grade.


Related News: China has a complete upstream and downstream industry chain, lower costs, and good talent reserves. It is one of the few industries in China that has an advantage in international competition.2-Fluoro-3-Methoxyphenylboronic Acid manufacturer With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.3-Bromo-5-hydroxypyridine supplier The novel coronavirus has resulted in thousands of confirmed human infections in more than 20 countries, with more than 99 percent of cases in China.Ethyl 1-(trifluoroMethyl)cyclopropanecarboxylate vendor The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.